This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Risch, N. Search for Related Content PubMed PubMed Citation Articles by Risch, N.

The Genetic Epidemiology of Cancer

Interpreting Family and Twin Studies and Their Implications for Molecular Genetic Approaches

Department of Genetics, Stanford University School of Medicine, Stanford, California 94305-5120, and Division of Research, Kaiser Permanente, Oakland, California 94611-5714

The recent completion of a rough draft of the human genome sequence has ushered in a new era of molecular genetics research into the inherited basis of a number of complex diseases such as cancer. At the same time, recent twin studies have suggested a limited role of genetic susceptibility to many neoplasms. A reappraisal of family and twin studies for many cancer sites suggests the following general conclusions: (a) all cancers are familial to approximately the same degree, with only a few exceptions (both high and low); (b) early age of diagnosis is generally associated with increased familiality; (c) familiality does not decrease with decreasing prevalence of the tumor-in fact, the trend is toward increasing familiality with decreasing prevalence; (d) a multifactorial (polygenic) threshold model fits the twin data for most cancers less well than single gene or genetic heterogeneity-type models; (e) recessive inheritance is less likely generally than dominant or additive models; (f) heritability decreases for rarer tumors only in the context of the polygenic model but not in the context of single-locus or heterogeneity models; (g) although the family and twin data do not account for gene-environment interactions or confounding, they are still consistent with genes contributing high attributable risks for most cancer sites. These results support continued search for genetic and environmental factors in cancer susceptibility for all tumor types. Suggestions are given for optimal study designs depending on the underlying architecture of genetic predisposition.

This article has been cited by other articles:

				M. D. Bacolod, G. S. Schemmann, S. Wang, R. Shattock, S. F. Giardina, Z. Zeng, J. Shia, R. F. Stengel, N. Gerry, J. Hoh, et al. The Signatures of Autozygosity among Patients with Colorectal Cancer Cancer Res., April 15, 2008; 68(8): 2610 - 2621. [Abstract] [Full Text] [PDF]

				S. V Ramagopalan, M. Knight, G. C Ebers, and J. C Knight Origins of magic: review of genetic and epigenetic effects BMJ, December 22, 2007; 335(7633): 1299 - 1301. [Abstract] [Full Text] [PDF]

				J. W. Knowles, T. L. Assimes, J. Li, T. Quertermous, and J. P. Cooke Genetic Susceptibility to Peripheral Arterial Disease: A Dark Corner in Vascular Biology Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2068 - 2078. [Abstract] [Full Text] [PDF]

				R. J. Hung, L. Moore, P. Boffetta, B.-J. Feng, J. R. Toro, N. Rothman, D. Zaridze, M. Navratilova, V. Bencko, V. Janout, et al. Family History and the Risk of Kidney Cancer: a Multicenter Case-control Study in Central Europe Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1287 - 1290. [Abstract] [Full Text] [PDF]

				W. D Hall A research agenda for assessing the potential contribution of genomic medicine to tobacco control Tob. Control, February 1, 2007; 16(1): 53 - 58. [Abstract] [Full Text] [PDF]

				K. HEMMINKI, A. FORSTI, and J. L. BERMEJO Gene-environment interactions in cancer: do they exist? Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 137 - 148. [Abstract] [Full Text] [PDF]

				E. Barroso, R.L. Milne, L.P. Fernandez, P. Zamora, J.I. Arias, J. Benitez, and G. Ribas FANCD2 associated with sporadic breast cancer risk Carcinogenesis, September 1, 2006; 27(9): 1930 - 1937. [Abstract] [Full Text] [PDF]

				K. Hemminki and B. Chen Familial risks for cervical tumors in full and half siblings: etiologic apportioning. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1413 - 1414. [Abstract] [Full Text] [PDF]

				S. G Baker and J. Kaprio Common susceptibility genes for cancer: search for the end of the rainbow. BMJ, May 13, 2006; 332(7550): 1150 - 1152. [Full Text] [PDF]

				Q. Yang, M. J Khoury, J. Friedman, J. Little, and W D. Flanders How many genes underlie the occurrence of common complex diseases in the population? Int. J. Epidemiol., October 1, 2005; 34(5): 1129 - 1137. [Abstract] [Full Text] [PDF]

				M Y M Ng, T Andrew, T D Spector, S Jeffery, and (representing the Lymphoedema Consortium) Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs J. Med. Genet., March 1, 2005; 42(3): 235 - 239. [Abstract] [Full Text] [PDF]

				G. P. Larson, Y. Ding, L. S-C. Cheng, C. Lundberg, V. Gagalang, G. Rivas, L. Geller, J. Weitzel, D. MacDonald, J. Archambeau, et al. Genetic Linkage of Prostate Cancer Risk to the Chromosome 3 Region Bearing FHIT Cancer Res., February 1, 2005; 65(3): 805 - 814. [Abstract] [Full Text] [PDF]

				K. A. Gould, M. Tochacek, B. S. Schaffer, T. M. Reindl, C. R. Murrin, C. M. Lachel, E. A. VanderWoude, K. L. Pennington, L. A. Flood, K. K. Bynote, et al. Genetic Determination of Susceptibility to Estrogen-Induced Mammary Cancer in the ACI Rat: Mapping of Emca1 and Emca2 to Chromosomes 5 and 18 Genetics, December 1, 2004; 168(4): 2113 - 2125. [Abstract] [Full Text] [PDF]

				K. Wirdefeldt, M. Gatz, M. Schalling, and N. L. Pedersen No evidence for heritability of Parkinson disease in Swedish twins Neurology, July 27, 2004; 63(2): 305 - 311. [Abstract] [Full Text] [PDF]

				D. J. Schaid The complex genetic epidemiology of prostate cancer Hum. Mol. Genet., April 1, 2004; 13(90001): R103 - 121. [Abstract] [Full Text] [PDF]

				H. W. Mohrenweiser Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm Toxicol Pathol, January 1, 2004; 32(1_suppl): 136 - 145. [Abstract] [PDF]

				K. R. Merikangas and N. Risch Genomic Priorities and Public Health Science, October 24, 2003; 302(5645): 599 - 601. [Abstract] [Full Text] [PDF]

				T. A. Dragani 10 Years of Mouse Cancer Modifier Loci: Human Relevance Cancer Res., June 15, 2003; 63(12): 3011 - 3018. [Abstract] [Full Text] [PDF]

				K. Q. Zhang, S. A. Salzman, D. J. Reding, B. K. Suarez, W. J. Catalona, and J. K. Burmester Genetics of Prostate Cancer Clin. Med. Res., January 1, 2003; 1(1): 21 - 28. [Abstract] [Full Text] [PDF]

				N. E. Caporaso Why Have We Failed to Find the Low Penetrance Genetic Constituents of Common Cancers? Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1544 - 1549. [Full Text] [PDF]

				K. Hemminki and K. Czene Attributable Risks of Familial Cancer from the Family-Cancer Database Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1638 - 1644. [Abstract] [Full Text] [PDF]

				D. J. Smith and A. J. Lusis The allelic structure of common disease Hum. Mol. Genet., October 1, 2002; 11(20): 2455 - 2461. [Abstract] [Full Text] [PDF]

				S. Wacholder, N. Rothman, and N. Caporaso Counterpoint: Bias from Population Stratification Is Not a Major Threat to the Validity of Conclusions from Epidemiological Studies of Common Polymorphisms and Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 513 - 520. [Full Text] [PDF]

				W Hall, P Madden, and M Lynskey The genetics of tobacco use: methods, findings and policy implications Tob. Control, June 1, 2002; 11(2): 119 - 124. [Abstract] [Full Text] [PDF]

				K. Hemminki and N. Risch Correspondence re: Risch, N.: Genetic Epidemiology of Cancer: Interpreting Family and Twin Studies and Their Implications for Molecular Genetic Approaches. Cancer Epidemiol. Biomark. Prev., 10: 733-741, 2001. Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 423 - 426. [Full Text] [PDF]